Bristol Myers Squibb’s Camzyos gets NICE recommendation
Therapy is used among adult patients with symptomatic obstructive hypertrophic cardiomyopathy
Read More
Tag: camzyos
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
